Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06209021 |
Other study ID # |
Audiology2024 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 2024 |
Est. completion date |
May 2024 |
Study information
Verified date |
January 2024 |
Source |
Assiut University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The goal of this observational study is to measure the effect of hyperbaric oxygen therapy on
middle ear pressure in order to predict the risk factors for middle ear barotrauma also, to
assess its effects on hearing functions of the inner ear in participant population. The main
questions aim to answer are:
- Is there a change in middle ear pressure before and after exposure to hyperbaric oxygen
therapy ?
- Is there a change in hearing threshold level before and after exposure to hyperbaric
oxygen therapy ? The middle ear pressure, eustachian tube functions and the hearing
threshold of the participants will be assessed immediately before the fist session and
within one hour after the first and tenth sessions.
Description:
Fifty four patients already treated by hyperbaric oxygen therapy recruited from hyperbaric
oxygen therapy center of Assiut university hospitals. Otoscopic examination for all patients
must be done before and after the session , assessment of middle ear pressure and the state
of the eustachian tube through doing eustachian tube function tests (Valsalva and Toynbee
tests for ears with intact tympanic membrane and modified inflation - deflation tests for
ears with perforated tympanic membrane) by tympanometry for all patients before and after the
first session of hjyperbaric oxygen therapy and after completion of the tenth session.
Assessment of the hearing threshold level of the patients immediately before the first
session and after the tenth session of hyperbaric oxygen therapy through doing pure tone
audiometry ( air conduction and bone conduction audiometry) and speech audiometry to assess
the speech discrimination score for the patients